![Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate Agnihotri S, Mittal RD, Ahmad S, Mandhani A - Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate Agnihotri S, Mittal RD, Ahmad S, Mandhani A -](https://www.indianjurol.com/articles/2014/30/1/images/IndianJUrol_2014_30_1_28_124202_t3.jpg)
Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate Agnihotri S, Mittal RD, Ahmad S, Mandhani A -
![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less. Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.](https://d3i71xaburhd42.cloudfront.net/bbc5bbcef53a29466addccfb1a86dca2e6a5abe5/2-Table1-1.png)
Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.
![Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy](https://www.frontiersin.org/files/Articles/656444/fonc-11-656444-HTML/image_m/fonc-11-656444-t001.jpg)
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
![Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/12aed22c0affb1decf9e7953f12f3a9fb0849553/22-Table2-1.png)
Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar
![SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection SciELO - Brasil - Prostatic specific antigen for prostate cancer detection Prostatic specific antigen for prostate cancer detection](https://minio.scielo.br/documentstore/1677-6119/rZqzS6ngfHjyJxNWvHmW5qy/975ba54879c3ed642b8aa78b3f1b3b744693e06a.gif)